Compositions of glycopyrronium salt for inhalation

Details for Australian Patent Application No. 2007264000 (hide)

Owner Novartis AG

Inventors Wirth, Wolfgang; Stowasser, Frank; Haeberlin, Barbara; Kieckbusch, Thomas; Kaerger, Sebastian; Baumberger, Anton; Abel, Stephan

Agent Davies Collison Cave

Pub. Number AU-B-2007264000

PCT Pub. Number WO2008/000482

Priority 0613161.9 30.06.06 GB

Filing date 28 June 2007

Wipo publication date 3 January 2008

Acceptance publication date 9 June 2011

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Event Publications

15 January 2009 PCT application entered the National Phase

  PCT publication WO2008/000482 Priority application(s): WO2008/000482

9 June 2011 Application Accepted

  Published as AU-B-2007264000

6 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007264001-Phenol derivatives for the treatment of respiratory diseases

2007263999-Applicator unit